Synergy CHC (SNYR)
NASDAQ:SNYR
Want to see SNYR full AI Analyst Report?
SNYR Stock Chart & Stats
$1.63
$0.16(3.75%)
At close: 4:00 PM EST
$1.63
$0.16(3.75%)
Day’s Range― - ―
52-Week Range$0.30 - $4.00
Previous CloseN/A
Volume8.10K
Average Volume (3M)136.07K
Market Cap
$5.77M
Enterprise Value$27.99M
Total Cash (Recent Filing)$2.62M
Total Debt (Recent Filing)$26.81M
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Jul 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.27
Shares Outstanding14,781,883
10 Day Avg. Volume89,526
30 Day Avg. Volume136,069
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.78
Price to Sales (P/S)0.60
P/FCF Ratio-7.00
Enterprise Value/Market Cap4.85
Enterprise Value/Revenue0.92
Enterprise Value/Gross Profit1.38
Enterprise Value/Ebitda-4.55
Forecast
1Y Price Target
$5.50Price Target Upside237.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.31
Revenue Forecast (FY)$44.71M
Bulls Say, Bears Say
Bulls Say
Analyst CoverageAnalyst initiates coverage of Synergy CHC with a BUY rating, reflecting external confidence in the company's growth trajectory.
Product Efficacy And Market OpportunityFOCUSfactor is a clinically tested brain health supplement and expanded into ready-to-drink and new SKUs, supporting potential to capture share in the fragmented brain health supplements market.
Retail Distribution ExpansionFOCUSfactor gained distribution in major retailers including Costco, CVS, and Walmart, broadening national retail presence and potential sales volume.
Bears Say
Competitive LandscapeHigh competition in the nutrition and wellness sector increases pricing pressure and makes sustainable differentiation more difficult.
Financial Performance ChallengesCompany faces sales, growth, and profitability challenges that could pressure earnings and investor confidence.
Investment And Execution RiskSales and growth headwinds combined with intense industry competition raise investment risk and may limit the company's ability to scale profitably.
Synergy CHC News
SNYR FAQ
What was Synergy CHC’s price range in the past 12 months?
Synergy CHC lowest stock price was $0.30 and its highest was $4.00 in the past 12 months.
What is Synergy CHC’s market cap?
Synergy CHC’s market cap is $5.77M.
When is Synergy CHC’s upcoming earnings report date?
Synergy CHC’s upcoming earnings report date is Jul 06, 2026 which is in 56 days.
How were Synergy CHC’s earnings last quarter?
Synergy CHC released its earnings results on Apr 01, 2026. The company reported -$1.35 earnings per share for the quarter, missing the consensus estimate of $0.03 by -$1.38.
Is Synergy CHC overvalued?
According to Wall Street analysts Synergy CHC’s price is currently Undervalued.
Does Synergy CHC pay dividends?
Synergy CHC does not currently pay dividends.
What is Synergy CHC’s EPS estimate?
Synergy CHC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synergy CHC have?
Synergy CHC has 14,781,883 shares outstanding.
What happened to Synergy CHC’s price movement after its last earnings report?
Synergy CHC reported an EPS of -$1.35 in its last earnings report, missing expectations of $0.03. Following the earnings report the stock price went down -20.93%.
Which hedge fund is a major shareholder of Synergy CHC?
Currently, no hedge funds are holding shares in SNYR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Synergy CHC
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was incorporated in 2010 and is based in Westbrook, Maine.
SNYR Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture. Material one-time charges (notably a $6.66M bad debt allowance, inventory and media write-offs, and a ~$2.9M license revenue reversal) produced large GAAP losses and pushed operating expenses and adjusted EBITDA down. Offsetting these negatives, management highlighted meaningful strategic progress: beverage early traction (Q1 2026 > all of 2025), Mexico subsidiary and Costco Mexico entry, expanded Kroger distribution, stronger cash and working capital, and management’s contention that normalized gross margins are healthy. Operational risks remain (Flat Tummy weakness, TV advertising not restarted, and elevated inventory levels), but management frames many of the financial setbacks as one-time items with a path to improved normalized performance. Overall, positives and negatives are balanced.View all SNYR earnings summariesSNYR Stock 12 Month Forecast
Average Price Target
$5.50
▲(237.42% Upside)
Technical Analysis
Ownership Overview
34.69% Insiders
4.46% Mutual Funds
6.68% Other Institutional Investors
53.56% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---